Sun Pharma Wins CDSCO Nod for Generic Oral Semaglutide Pill
Sun Pharmaceutical Industries has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market a generic […]
Sun Pharmaceutical Industries has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market a generic […]
Regulators have stopped Sun Pharma from making and selling eye-care drugs from its Assam plant over quality system failures, with 332 recalled batches under review.
Sun Pharma’s Q2 FY27 revenue rose 11.9% to ₹16,198.7 crore on a 17.3% jump in India formulations, while US sales fell 8.3% and a one-time loss pulled reported profit down 32%.
India’s medicine sales rose 12% to ₹70,180 crore in the September quarter, a fourth straight double-digit gain led by cardiac, diabetes and cancer drugs.
The US FDA has approved Sun Pharma’s sBLA for ILUMYA (tildrakizumab-asmn) in adults with active psoriatic arthritis, backed by the Phase 3 INSPIRE-1 and INSPIRE-2 studies. The provider-administered IL-23 inhibitor, approved for plaque psoriasis since 2018, now addresses a US PsA population of about 2.4 million.
China’s drug regulator, the National Medical Products Administration (NMPA), has ordered a halt to the import, sale and use of […]
Mumbai-based Sun Pharmaceutical Industries Ltd. has announced the commercial launch of Unloxcyt (cosibelimab-ipdl) in the United States following an updated […]
Mumbai-headquartered Sun Pharmaceutical Industries, India’s largest drug manufacturer, is placing significant bets on speciality drugs to drive future growth. The […]
The pandemic was a truly Black Swan event. We’ve seen supply chain disruptions in the past, but the magnitude of […]
According to the US health agency, Sun Pharmaceutical Industries, a major pharmaceutical company, is recalling pre-filled syringes of a medication […]
Sun Pharmaceutical Industries revealed that it acquired a small share in both Agatsa Software Private Limited and Remidio Innovative Solutions […]
Drug major Sun Pharma has inked a licensing pact with AstraZeneca UK to introduce certain novel ready-to-use infusion oncology products […]
Sun Pharmaceutical Industries on Thursday said one of its arms has entered into a licensing pact with a subsidiary of […]